Summary of warrants outstanding |
The following is a summary of activity
in the number of warrants outstanding to purchase the Companys common stock for the year ended December 31, 2015 (in thousands):
|
|
Warrants accounted for as: |
|
|
Warrants accounted for as: |
|
|
|
|
|
|
Equity |
|
|
Liabilities |
|
|
|
|
|
|
January 2012 warrants |
|
|
March 2013 warrants |
|
|
April 2013 warrants |
|
|
February 2012 warrants |
|
|
August 2013 warrants |
|
|
October 2013 warrants |
|
|
October 2013 Series A warrants |
|
|
January 2014 warrants |
|
|
Total |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding, January 1, 2014 |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
Warrants acquired in merger with Biozone |
|
|
650 |
|
|
|
455 |
|
|
|
1,864 |
|
|
|
1,000 |
|
|
|
10,000 |
|
|
|
200 |
|
|
|
7,000 |
|
|
|
- |
|
|
|
21,169 |
|
Warrants issued |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
5,500 |
|
|
|
5,500 |
|
Outstanding, December 31, 2014 |
|
|
650 |
|
|
|
455 |
|
|
|
1,864 |
|
|
|
1,000 |
|
|
|
10,000 |
|
|
|
200 |
|
|
|
7,000 |
|
|
|
5,500 |
|
|
|
26,169 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants exercised |
|
|
- |
|
|
|
- |
|
|
|
(364 |
) |
|
|
- |
|
|
|
(10,000 |
) |
|
|
(200 |
) |
|
|
(6,325 |
) |
|
|
(1,500 |
) |
|
|
(18,389 |
) |
Outstanding, December 31, 2015 |
|
|
650 |
|
|
|
455 |
|
|
|
1,500 |
|
|
|
1,000 |
|
|
|
- |
|
|
|
- |
|
|
|
675 |
|
|
|
4,000 |
|
|
|
8,280 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expiration date |
|
January 11, 2016 |
|
|
March 1, 2016 |
|
|
April 25, 2018 |
|
|
February 28, 2016 |
|
|
August 26, 2023 |
|
|
October 18, 2018 |
|
|
October 24, 2023 |
|
|
January 16, 2024 |
|
|
|
|
|
|